Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

862
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
862
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

212
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
212
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

668
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
668
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

284
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
284
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

31
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
Liver Physiology01:30

Liver Physiology

1.1K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

Reviews in endocrine & metabolic disorders·2026
Same author

Assessing Europe's policy readiness to confront the MASLD/MASH public health threat.

The Lancet regional health. Europe·2026
Same author

Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

Reviews in endocrine & metabolic disorders·2026
Same author

Soluble endoglin as a marker of clinically significant portal hypertension in patients with cirrhosis.

Scientific reports·2026
Same author

PROCESS: a multimethods protocol to develop principles to operationalise community engagement, equity and sustainability in South Asian Health Research in Canada.

BMJ open·2026
Same author

Analyses of <i>ATP7B</i> mRNA in Nasopharyngeal Swab Samples Increase Yields of Wilson Disease Molecular Genetic Diagnostics.

Human mutation·2026

Related Experiment Video

Updated: Sep 7, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K

Statins and liver.

Jiří Hlušička, Mahak Arora, Radan Brůha

    Casopis Lekaru Ceskych
    |June 21, 2022
    PubMed
    Summary

    Statins, used to lower cholesterol, may also benefit patients with non-alcoholic fatty liver disease (NAFLD). Research suggests these drugs have pleiotropic effects that could treat NAFLD, a condition linked to obesity and unhealthy lifestyles.

    Area of Science:

    • Hepatology
    • Pharmacology
    • Cardiovascular Medicine

    Background:

    • Statins are primary hypolipidemic agents inhibiting cholesterol synthesis via HMG-CoA reductase, significantly reducing cardiovascular risk.
    • Non-alcoholic fatty liver disease (NAFLD) is a growing concern in hepatology, associated with unhealthy lifestyles, obesity, and elevated blood lipids.
    • While statins are generally safe, potential side effects are rare and usually not severe.

    Purpose of the Study:

    • To explore the potential therapeutic role of statins in treating non-alcoholic fatty liver disease (NAFLD).
    • To highlight the pleiotropic effects of statins beyond lipid-lowering.
    • To draw attention to emerging research on statins for NAFLD management.

    Main Methods:

    • Review of recent scientific literature on statin pharmacology and NAFLD.
    Keywords:
    NAFLDdyslipidemiehepatopathystatins

    More Related Videos

    LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
    08:45

    LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

    Published on: November 17, 2018

    13.5K
    Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
    08:58

    Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

    Published on: March 11, 2017

    16.1K

    Related Experiment Videos

    Last Updated: Sep 7, 2025

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
    09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

    14.7K
    LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
    08:45

    LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

    Published on: November 17, 2018

    13.5K
    Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
    08:58

    Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

    Published on: March 11, 2017

    16.1K
  • Analysis of studies investigating the effects of statins in patients with NAFLD.
  • Examination of the pleiotropic mechanisms of statins relevant to liver health.

    • Main Results:

    • Recent studies indicate beneficial effects of statin administration in patients diagnosed with NAFLD.
    • Statins exhibit pleiotropic actions that may extend beyond cholesterol reduction.
    • Evidence suggests statins could be a future treatment option for NAFLD.

    Conclusions:

    • Statins show promise for the treatment of non-alcoholic fatty liver disease.
    • The pleiotropic effects of statins warrant further investigation for hepatic applications.
    • Statins may offer a novel therapeutic strategy for managing NAFLD.